Adverse drug events in critically ill patients with cancer: Incidence, characteristics, and outcomes

Journal of Pharmacy Practice

Volumn 27, Issue 2, 2014, Pages 208-213

  Nazer, Lama H ^a   Hawari, Feras ^a   Al Najjar, Taghreed ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

adverse drug event; cancer; characteristics; incidence; intensive care unit

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; CARDIOVASCULAR AGENT; HYPERTENSIVE FACTOR; INSULIN; SEDATIVE AGENT; STEROID; ANTINEOPLASTIC AGENT;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CANCER PATIENT; CRITICALLY ILL PATIENT; FEMALE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; LIFE THREAT; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PATIENT SAFETY; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK FACTOR; SEX RATIO; UNSPECIFIED SIDE EFFECT; AGED; CRITICAL ILLNESS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CRITICAL ILLNESS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84898993427     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190013513302     Document Type: Article

References (22)

1. Rothschild JM, Landrigan CP, Cronin JW, et al. The critical care safety study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005 ; 33 (8). 1694-1700
2. Kane-Gill S, Rea RS, Verrico MM, et al. Adverse drug event rates for high cost and high use drugs in the intensive care unit. Am J Health Syst Pharm. 2006 ; 63 (19). 1876-1881
3. Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med. 2006 ; 34 (2). 415-425
4. Benkiran RR, Abouqal RR, Haimeur CC, et al. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study. J Patient Saf. 2009 ; 5 (1). 16-22
5. Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009 ; 18 (7). 639-645
6. Reis AM, Cassiani SH. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol. 2011 ; 67 (6). 625-632
7. Bates DW, Cullen DJ, Lair N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995 ; 274 (1). 29-34
8. Cullen DJ, Sweitzer BJ, Bates DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997 ; 25 (8). 1289-1297
9. Vargas E, Terleira A, Hernando F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med. 2003 ; 31 (3). 694-698
10. Kaushal R, Bates DW, Franz C, et al. Costs of adverse events in intensive care units. Crit Care Med. 2007 ; 35 (11). 479-483
11. Nuckols TK, Paddock SM, Bower AG, et al. Costs of intravenous adverse drug events in academic and nonacademic intensive care units. Med Care. 2008 ; 46 (1). 17-24
12. Forster AJ, Kyeremanteng K, Hooper J, et al. The impact of adverse events in the intensive care unit on hospital mortality and length of stay. BMC Health Serv Res. 2008 ; 8: 259
13. Hawari FI, Al Najjar TI, Zaru L, et al. The effect of implementing high-intensity intensive care unit staffing model in outcome of critically ill oncology patients. Crit Care Med. 2009 ; 37 (6). 1967-1971
14. Resar RK, Rozich JD, Simmonds T, et al. A trigger tool to identify adverse events in the intensive care unit. Jt Comm J Qual Patient Saf. 2006 ; 32 (10). 585-590
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 ; 30 (2). 239-245
16. Wilmer A, Louie K, Dodek P, et al. Incidence of medication errors and adverse drug events in the ICU: a systematic review. Qual Saf Health Care. 2010 ; 19 (5). e7
17. Chawla LS, Abell L, Mazhari R, et al. Identifying critically ill patients at high risk for developing acute renal failure: a pilot study. Kidney Int. 2005 ; 68 (5). 2274-2280
18. de Mendonca A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000 ; 26 (7). 915-921
19. Kane-Gill SL, Kirisci L, Verrico MM, et al. Analysis of risk factors for adverse drug events in critically ill patients. Crit Care Med. 2012 ; 40 (3). 823-828
20. Moghissi ES. Addressing hyperglycemia from hospital admission to discharge. Curr Med Res Opin. 2010 ; 26 (3). 589-598
21. Golightly LK, Jones MA, Hamamura KH, et al. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006 ; 26 (10). 1421-1431
22. Shulman R, Singer M, Goldstone J, et al. Medication errors: a prospective cohort study of hand-written computerised physician order entry in the intensive care unit. Crit Care. 2005 ; 9 (5). R516 - R521